Literature DB >> 7049079

Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex.

C D Fitch, R Chevli, H S Banyal, G Phillips, M A Pfaller, D J Krogstad.   

Abstract

Ferriprotoporphyrin IX (FP) and a chloroquine-FP complex lysed isolated Plasmodium falciparum parasites as judged by decreases in the turbidity of parasite suspensions and by ultrastructural changes. Exposure of parasite suspensions to 50 microM FP or to a complex formed from 50 microM FP and 20 MicroM chloroquine reduced the number of identifiable parasites and caused swelling and loss of internal detail in those that were identifiable. The amount of lysis was dose-dependent over the range of 10 to 50 microM FP. Formation of a chloroquine-FP complex reduced, but did not eliminate, the toxicity of FP. Since there is evidence indicating that a chloroquine-FP complex forms when chloroquine-susceptible parasites are exposed to chloroquine, we suggest that accumulation of this complex may account for the chemotherapeutic effect of chloroquine against P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049079      PMCID: PMC182018          DOI: 10.1128/AAC.21.5.819

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Heme lysis of the bloodstream forms of Trypanosoma brucei.

Authors:  S R Meshnick; K P Chang; A Cerami
Journal:  Biochem Pharmacol       Date:  1977-10-15       Impact factor: 5.858

2.  Plasmodium falciparum: microaerophilic requirements in human red blood cells.

Authors:  L W Scheibel; S H Ashton; W Trager
Journal:  Exp Parasitol       Date:  1979-06       Impact factor: 2.011

3.  Freeze-fracture study of malaria sporozoites: antibody-induced changes of the pellicular membrane.

Authors:  M Aikawa; A H Cochrane; R S Nussenzweig; J Rabbege
Journal:  J Protozool       Date:  1979-05

4.  Pigment in asexual erythrocytic forms of chloroquine-resistant Plasmodium falciparum.

Authors:  J V McNamara; K H Rieckmann; R D Powell
Journal:  Ann Trop Med Parasitol       Date:  1967-06

5.  Plasmodium falciparum in owl monkeys: drug resistance and chloroquine binding capacity.

Authors:  C D Fitch
Journal:  Science       Date:  1970-07-17       Impact factor: 47.728

6.  Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). I. The courses of untreated infections.

Authors:  L H Schmidt
Journal:  Am J Trop Med Hyg       Date:  1978-07       Impact factor: 2.345

7.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

8.  Activity of two chlorinated lincomycin analogues against chloroquine-resistant falciparum malaria in owl monkeys.

Authors:  K G Powers; R L Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

9.  Chloroquine resistance in malaria: a deficiency of chloroquine binding.

Authors:  C D Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1969-12       Impact factor: 11.205

10.  Chloroquine-resistant Plasmodium falciparum: effect of substrate on chloroquine and amodiaquin accumulation.

Authors:  C D Fitch; R Chevli; Y Gonzalez
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

View more
  22 in total

1.  On the preparation of beta-haematin.

Authors:  G Blauer; M Akkawi
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

2.  Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum.

Authors:  Cecilia P Sanchez; Petra Rohrbach; Jeremy E McLean; David A Fidock; Wilfred D Stein; Michael Lanzer
Journal:  Mol Microbiol       Date:  2007-04       Impact factor: 3.501

Review 3.  Antimalarial agents: mechanisms of action.

Authors:  P H Schlesinger; D J Krogstad; B L Herwaldt
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

Review 4.  Involvement of heme in the antimalarial action of chloroquine.

Authors:  C D Fitch
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

5.  Curcumin-artemisinin combination therapy for malaria.

Authors:  Dalavaikodihalli Nanjaiah Nandakumar; Viswanathan Arun Nagaraj; Palakkod Govindan Vathsala; Pundi Rangarajan; Govindarajan Padmanaban
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

6.  Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum.

Authors:  N Surolia; G Padmanaban
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  A comparative study on the effect of chloroquine and ammonium chloride on feeding process of Plasmodium falciparum in vitro.

Authors:  Y Zhang; W W Just
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

8.  Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitro.

Authors:  Florence Dzierszinski; Alexandra Coppin; Marlene Mortuaire; Etienne Dewailly; Christian Slomianny; Jean-Claude Ameisen; Frederic DeBels; Stanislas Tomavo
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 9.  Malaria biology and disease pathogenesis: insights for new treatments.

Authors:  Louis H Miller; Hans C Ackerman; Xin-zhuan Su; Thomas E Wellems
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

10.  The single crystal X-ray structure of β-hematin DMSO solvate grown in the presence of chloroquine, a β-hematin growth-rate inhibitor.

Authors:  Johandie Gildenhuys; Tanya le Roex; Timothy J Egan; Katherine A de Villiers
Journal:  J Am Chem Soc       Date:  2013-01-09       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.